Page last updated: 2024-09-05

tesaglitazar and Hyperglycemia, Postprandial

tesaglitazar has been researched along with Hyperglycemia, Postprandial in 2 studies

*Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Henke, BR1
Birketvedt, GS; Fagerberg, B; Gause-Nilsson, I; Ohman, KP; Schuster, H; Tonstad, S1

Reviews

1 review(s) available for tesaglitazar and Hyperglycemia, Postprandial

ArticleYear
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
    Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17

    Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2004

Trials

1 trial(s) available for tesaglitazar and Hyperglycemia, Postprandial

ArticleYear
Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARalpha/gamma agonist, tesaglitazar.
    Diabetes & vascular disease research, 2007, Volume: 4, Issue:3

    Topics: Adult; Alkanesulfonates; Blood Glucose; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin Resistance; Lipids; Male; Middle Aged; Phenylpropionates; Postprandial Period; PPAR alpha; PPAR gamma; Triglycerides

2007